David Madden
Corporate Officer/Principal chez KINNATE BIOPHARMA INC.
Profil
David Madden is currently the Treasurer & Director at Can Do Multiple Sclerosis and the Vice President-Finance at Kinnate Biopharma, Inc. Previously, he worked as the Associate Director-Corporate Finance at Chiron Corp., the Director-Investment Analysis at PG&E Enterprises, the Senior Director-Finance at Emergent Travel Health, Inc., the Chief Financial Officer & Director at Nanotech Biomachines, Inc., the Chief Financial Officer at CareDx, Inc., the Chief Financial Officer at Arriva Pharmaceuticals, Inc. from 2007 to 2011, the Chief Financial Officer at Vaxart, Inc., and the Chief Financial Officer at Alector, Inc. Mr. Madden holds an MBA degree from the University of Washington and an undergraduate degree from the University of California, Berkeley.
Postes actifs de David Madden
| Sociétés | Poste | Début |
|---|---|---|
| KINNATE BIOPHARMA INC. | Corporate Officer/Principal | - |
Can Do Multiple Sclerosis
 Can Do Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services Can Do Multiple Sclerosis provides lifestyle empowerment programs. The company was founded in 1984 and is located in Edwards, CO. | Director/Board Member | 15/11/2010 |
Anciens postes connus de David Madden
| Sociétés | Poste | Fin |
|---|---|---|
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Director of Finance/CFO | 08/05/2014 |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Director of Finance/CFO | 19/01/2011 |
| CAREDX, INC | Director of Finance/CFO | 02/01/1910 |
| ALECTOR, INC. | Director of Finance/CFO | - |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de David Madden
| University of Washington | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CAREDX, INC | Health Technology |
| ALECTOR, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| PG&E Enterprises | |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Health Technology |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Nanotech Biomachines, Inc.
 Nanotech Biomachines, Inc. BiotechnologyHealth Technology Nanotech Biomachines, Inc. produces industrial-grade grapheme. It offers are used for computer transistors, radio-frequency transistors for cell phones, batteries, solar cells, printable electronics and touch displays. The company was by founded by Will Martinez and is headquartered in Berkeley, CA. | Health Technology |
Can Do Multiple Sclerosis
Can Do Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services Can Do Multiple Sclerosis provides lifestyle empowerment programs. The company was founded in 1984 and is located in Edwards, CO. | Commercial Services |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
